Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2021-09-14 00:00:00 ET · period of report 2021-09-13 · accession 0001209191-21-055867 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-14 | 2021-09-13 | FATE | Valamehr Bahram | Chief Development Off | M - OptEx | $2.73 | +25.0K | 120.7K | +26% | +$68.2K |
| DM | 2021-09-14 | 2021-09-13 | FATE | Valamehr Bahram | Chief Development Off | S - Sale+OE | $66.29 | -25.0K | 104.9K | -19% | -$1.66M |
| D | 2021-09-14 | 2021-09-13 | FATE | Valamehr Bahram | Chief Development Off | M - OptEx | $0.00 | -25.0K | 86.2K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-13 | M | A | 25,000 | $2.73 | 120,740 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-13 | S | D | 800 | $67.46 | 95,740 | D | — | — | (F4) Represents the weighted average sale price of the shares sold from $67.40 to $67.54 per share. |
| 3 | Common | Common Stock | 2021-09-13 | S | D | 8,391 | $66.84 | 96,540 | D | — | — | (F3) Represents the weighted average sale price of the shares sold from $66.40 to $67.38 per share. |
| 4 | Common | Common Stock | 2021-09-13 | S | D | 15,809 | $65.94 | 104,931 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $65.40 to $66.38 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-09-13 | M | D | 25,000 | $0.00 | 86,156 | D | $2.73 · — to 2027-01-04 | 25,000 Common Stock | (F5) This option is fully vested. |